The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: approaches to control rate in atrial fibrillation.

By B. Olshansky, L. Rosenfeld, A. Warner, A. Solomon, G. O’Neill, Arjun D Sharma, E. Platia, G. Feld, T. Akiyama, M. Brodsky and 2 more. Journal of the American College of Cardiology, 2004

596 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine

View Paper: https://www.semanticscholar.org/paper/bd1ee78708150f3a4222cb6373c25d80fd974479

Citations in the corpus

• 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. (2014, unknown): “Reasonable to perform AV node ablation with ventricular pacing to control heart rate when pharmacological therapy insufficient or not tolerated IIa B (95, 185, 186)”
• ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Commit (2006, unknown): “With or without digoxin in the AFFIRM study, beta blockers were the most effective drug class for rate control, achieving the specified heart rate endpoints in 70% of patients compared with 54% with use of calcium channel blockers (360).”